Brain arteriovenous malformations (BAVM) are usually detected only when the patient presents with intracranial hemorrhages, seizures, headaches, focal neurological deficits, or other disorders. A smaller number are detected incidentally. Although BAVM themselves are rare, the severity of the clinical presentations underscores the need for a better understanding of etiology, natural history, and prognosis of the disorder. The primary reason for treating BAVM is the prevention of intracranial hemorrhage. However, the risk associated with treatment must be weighed against that of natural history of BAVM, on which there is little data. In addition, there is controversy involving the relative efficacies of the 2 most practiced treatment modalities: open surgery and stereotactic radiosurgery. Most of what is known about BAVM comes from referral series. There is a paucity of data from population-based studies. In this project, we will examine patient and BAVM characteristics in relation to BAVM presentation and subsequent hemorrhage using both referral-based and population-based data. We will especially focus on the epidemiological issues involved in BAVM research methodologies. Our project will also investigate the settings for clinical equipoise in BAVM treatment using an improved observational study design. Results of this latter analysis will significantly contribute to the planning of a future randomized clinical trial for BAVM treatment, comparing open surgery with radiosurgery. This proposed project will serve as a critical training experience for the Principal Investigator, by affording him the opportunity to apply his epidemiological background and augment his research skills in preparation for independent scientific research. The results of this project may additionally further our understanding of the natural history and risk factors for intracranial hemorrhages in patients with BAVM, as well as evaluate the safety and efficacy of the different treatment modalities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08NS042359-01A1
Application #
6469937
Study Section
NST-2 Subcommittee (NST)
Program Officer
Jacobs, Tom P
Project Start
2002-06-01
Project End
2003-05-31
Budget Start
2002-06-01
Budget End
2003-05-31
Support Year
1
Fiscal Year
2002
Total Cost
$130,596
Indirect Cost
Name
University of California San Francisco
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Thomson, Kyle E; Modi, Avani C; Glauser, Tracy A et al. (2017) The impact of nonadherence to antiseizure drugs on seizure outcomes in an animal model of epilepsy. Epilepsia 58:1054-1062
Kaufmann, Dan; West, Peter J; Smith, Misty D et al. (2017) sec-Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory pain. Pharmacol Res 117:129-139
Trandafir, C C; Pouliot, W A; Dudek, F E et al. (2015) Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus. Neuroscience 284:601-10
Zayachkivsky, A; Lehmkuhle, M J; Ekstrand, J J et al. (2015) Ischemic injury suppresses hypoxia-induced electrographic seizures and the background EEG in a rat model of perinatal hypoxic-ischemic encephalopathy. J Neurophysiol 114:2753-63
Mawasi, Hafiz; Shekh-Ahmad, Tawfeeq; Finnell, Richard H et al. (2015) Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide--Amide derivatives of valproic acid. Epilepsy Behav 46:72-8
Thomson, Kyle E; White, H Steve (2014) A novel open-source drug-delivery system that allows for first-of-kind simulation of nonadherence to pharmacological interventions in animal disease models. J Neurosci Methods 238:105-11
Shekh-Ahmad, Tawfeeq; Hen, Naama; Yagen, Boris et al. (2014) Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential. Epilepsia 55:353-61
Srivastava, Ajay K; Alex, Anitha B; Wilcox, Karen S et al. (2013) Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy. Epilepsia 54:1186-94
Pouliot, W; Bialer, M; Hen, N et al. (2013) A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus. Neuroscience 231:145-56
Srivastava, Ajay K; White, H Steve (2013) Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats. Epilepsy Res 104:26-34

Showing the most recent 10 out of 38 publications